ACLU Takes Federal Government to Court Over Abortion Pill Restrictions

It’s arguing that a decade-old FDA rule places an “undue burden” on women.

Protestors rally outside of the Supreme Court on March 2, 2016 during oral arguments in the Whole Woman's Health v. Hellerstedt case.Douliery Olivier/Sipa via AP Images

For indispensable reporting on the coronavirus crisis, the election, and more, subscribe to the Mother Jones Daily newsletter.

On Tuesday, the American Civil Liberties Union sued the Food and Drug Administration over the agency’s restrictions on medication abortion. The lawsuit, filed in a U.S. District Court on behalf of a Hawaii doctor and several health care associations, specifically targets a restriction on mifepristone, a common drug used in medication abortion. 

Medication abortion involves two drugs, mifepristone and misoprostol. The FDA’s current rules, implemented in 2007, only allow mifepristone to be dispensed at a medical facility, like a doctor’s office or a clinic. By contrast, misoprostol is available at pharmacies with a prescription. Dr. Graham Chelius, a family medicine doctor in Hawaii and a plaintiff in the suit, says that the mifepristone restriction has made it nearly impossible for patients in rural Hawaii to access the procedure at all. That’s because, he says, some hospitals in the state, including his own, don’t stock mifepristone. 

“Because of the FDA’s restrictions,” said Chelius in a press release, “my patients are forced either to fly to a different provider on another island—resulting in serious delays—or to carry a pregnancy to term against their will.” According to the lawsuit, carrying a pregnancy to term poses a risk of fatality that is fourteen times greater than taking Mileprex, the brand name for mifepristone.

“The FDA restrictions harm patients by delaying time sensitive healthcare, imposing needless costs, and blocking some women from accessing abortion at all,” Julia Kaye, a staff attorney with the ACLU’s Reproductive Freedom Project, told reporters. 

More than a third of people who choose to end their pregnancies use medication abortion to do so, according to the Guttmacher Institute.

Chelius and the ACLU are hoping to overturn the FDA rule, which would then allow patients to pick up prescriptions for mifepristone at their local pharmacy and expand access to the procedure for low-income and rural women. 

“This case is about where a woman is standing when the pill is handed to her,” says Kaye. “This is about abortion stigma, not science.” 

DOES IT FEEL LIKE POLITICS IS AT A BREAKING POINT?

Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend

Latest